# Chongqing Kangle Pharmaceutical Co., Ltd – FDA Inspection, Sep 5, 2025

Source: https://www.keypedia.com/records/fda_inspections/chongqing-kangle-pharmaceutical-co-ltd/0ae9e965-0baa-4ae0-ae7f-b42f8e6e62b6
Source feed: FDA_Inspections

> FDA inspection 1286254 of Chongqing Kangle Pharmaceutical Co., Ltd, September 05, 2025. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1286254
- Company Name: Chongqing Kangle Pharmaceutical Co., Ltd
- Inspection Date: 2025-09-05
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1064345 - 2018-07-26](https://www.keypedia.com/records/fda_inspections/chongqing-kangle-pharmaceutical-co-ltd/d6272298-6c9d-42d7-b3ad-95df1968b5f5)
- FDA Inspection 912714 - 2015-01-30
- FDA Inspection 783920 - 2012-04-26

## Related Officers

- [Tonia F. Bernard](https://www.keypedia.com/people/tonia-f-bernard/607c8dae-63cb-491a-8d7d-ddfa0ee1b67d)

Company: https://www.keypedia.com/companies/chongqing-kangle-pharmaceutical-co-ltd/10ee20e7-7e03-4bf3-835f-53e9c3c8ebfc

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
